Order Article Reprints

Lo Y-L, Wang T-Y, Chen C-J, Chang Y-H, Lin AM-Y. Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer. Pharmaceutics. 2022; 14(9):1759. https://doi.org/10.3390/pharmaceutics14091759

Lo, Yu-Li, Tse-Yuan Wang, Chun-Jung Chen, Yih-Hsin Chang, and Anya Maan-Yuh Lin. 2022. "Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer" Pharmaceutics 14, no. 9: 1759. https://doi.org/10.3390/pharmaceutics14091759

Lo, Y.-L., Wang, T.-Y., Chen, C.-J., Chang, Y.-H., & Lin, A. M.-Y. (2022). Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer. Pharmaceutics, 14(9), 1759. https://doi.org/10.3390/pharmaceutics14091759